Search All News
Studies exploring metformin’s power to prevent prostate cancer progression have been inconclusive. Columbia research now shows that the drug has promise, but only for specific patients.
- June 1, 2021
Larisa Geskin's first lobbying success led New York state to prohibit indoor tanning for children. Now she's urging Medicaid to help low-income families access sunscreen.
- May 24, 2021
Many women and their physicians stick to annual Pap and HPV tests, Columbia researchers have found, despite new guidelines recommending less frequent cervical cancer screening.
- May 21, 2021
Columbia cancer researchers are testing a new chemotherapy regimen for patients with an invasive form of bladder cancer who have limited options beyond radical surgery if initial treatment fails.
- May 20, 2021
Newly identified immune cells infiltrate tumors in patients with localized kidney cancer and may be driving the cancer’s recurrence, Columbia researchers have found.
- May 18, 2021
Christine Iok In Chio and Xuebing Wu have received 2021 Pershing Square Sohn Prizes for their out-of-the box approaches to cancer research.
- May 10, 2021
Scientists have found that many esophageal cancers turn on ancient viral DNA embedded in our genome, a finding that could lead to improvements in immunotherapy.
- April 2, 2021
In a new study, Columbia cancer researchers have identified a potential new drug target in lung metastases of esophageal squamous cell carcinoma.
- March 24, 2021
Columbia cancer researchers are working to increase the representation of people of color in cancer clinical trials and decrease the health equity gap, with the help of Stand Up to Cancer.
- March 11, 2021
Reducing levels of a hormone prevented metastasis and prolonged survival in mice with pancreatic cancer, a study from Columbia has found, which could lead to new treatments for patients.
- March 1, 2021
Using a new technique that uncovers the hidden tricks cancer cells use to resist immunotherapy, Columbia and MIT researchers have discovered why some melanoma patients do not respond to the therapy.